Pyrrolopyrimidine compounds and their uses
The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BESONG GILBERT EBAI LI YUE SUNG MOO JE DAGOSTIN CLAUDIO BROOKS CLINTON ALAN HE GUO HOWARD STEVEN WRONA WOJCIECH LAGU BHARAT SMITH TROY D WOODHEAD STEVEN JOHN MORTENSON PAUL NEIL BRAIN CHRISTOPHER THOMAS CONGREVE MILES STUART HOU YING LU YIPIN |
| description | The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8685980B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8685980B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8685980B23</originalsourceid><addsrcrecordid>eNrjZNAKqCwqys_JL6gsyszNTMnMS1VIzs8tyC_NSylWSMxLUSjJSM0sUigtTi3mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWZhamlhYGTkbGRCgBADipKZM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pyrrolopyrimidine compounds and their uses</title><source>esp@cenet</source><creator>BESONG GILBERT EBAI ; LI YUE ; SUNG MOO JE ; DAGOSTIN CLAUDIO ; BROOKS CLINTON ALAN ; HE GUO ; HOWARD STEVEN ; WRONA WOJCIECH ; LAGU BHARAT ; SMITH TROY D ; WOODHEAD STEVEN JOHN ; MORTENSON PAUL NEIL ; BRAIN CHRISTOPHER THOMAS ; CONGREVE MILES STUART ; HOU YING ; LU YIPIN</creator><creatorcontrib>BESONG GILBERT EBAI ; LI YUE ; SUNG MOO JE ; DAGOSTIN CLAUDIO ; BROOKS CLINTON ALAN ; HE GUO ; HOWARD STEVEN ; WRONA WOJCIECH ; LAGU BHARAT ; SMITH TROY D ; WOODHEAD STEVEN JOHN ; MORTENSON PAUL NEIL ; BRAIN CHRISTOPHER THOMAS ; CONGREVE MILES STUART ; HOU YING ; LU YIPIN</creatorcontrib><description>The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140401&DB=EPODOC&CC=US&NR=8685980B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140401&DB=EPODOC&CC=US&NR=8685980B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BESONG GILBERT EBAI</creatorcontrib><creatorcontrib>LI YUE</creatorcontrib><creatorcontrib>SUNG MOO JE</creatorcontrib><creatorcontrib>DAGOSTIN CLAUDIO</creatorcontrib><creatorcontrib>BROOKS CLINTON ALAN</creatorcontrib><creatorcontrib>HE GUO</creatorcontrib><creatorcontrib>HOWARD STEVEN</creatorcontrib><creatorcontrib>WRONA WOJCIECH</creatorcontrib><creatorcontrib>LAGU BHARAT</creatorcontrib><creatorcontrib>SMITH TROY D</creatorcontrib><creatorcontrib>WOODHEAD STEVEN JOHN</creatorcontrib><creatorcontrib>MORTENSON PAUL NEIL</creatorcontrib><creatorcontrib>BRAIN CHRISTOPHER THOMAS</creatorcontrib><creatorcontrib>CONGREVE MILES STUART</creatorcontrib><creatorcontrib>HOU YING</creatorcontrib><creatorcontrib>LU YIPIN</creatorcontrib><title>Pyrrolopyrimidine compounds and their uses</title><description>The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAKqCwqys_JL6gsyszNTMnMS1VIzs8tyC_NSylWSMxLUSjJSM0sUigtTi3mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWZhamlhYGTkbGRCgBADipKZM</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>BESONG GILBERT EBAI</creator><creator>LI YUE</creator><creator>SUNG MOO JE</creator><creator>DAGOSTIN CLAUDIO</creator><creator>BROOKS CLINTON ALAN</creator><creator>HE GUO</creator><creator>HOWARD STEVEN</creator><creator>WRONA WOJCIECH</creator><creator>LAGU BHARAT</creator><creator>SMITH TROY D</creator><creator>WOODHEAD STEVEN JOHN</creator><creator>MORTENSON PAUL NEIL</creator><creator>BRAIN CHRISTOPHER THOMAS</creator><creator>CONGREVE MILES STUART</creator><creator>HOU YING</creator><creator>LU YIPIN</creator><scope>EVB</scope></search><sort><creationdate>20140401</creationdate><title>Pyrrolopyrimidine compounds and their uses</title><author>BESONG GILBERT EBAI ; LI YUE ; SUNG MOO JE ; DAGOSTIN CLAUDIO ; BROOKS CLINTON ALAN ; HE GUO ; HOWARD STEVEN ; WRONA WOJCIECH ; LAGU BHARAT ; SMITH TROY D ; WOODHEAD STEVEN JOHN ; MORTENSON PAUL NEIL ; BRAIN CHRISTOPHER THOMAS ; CONGREVE MILES STUART ; HOU YING ; LU YIPIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8685980B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BESONG GILBERT EBAI</creatorcontrib><creatorcontrib>LI YUE</creatorcontrib><creatorcontrib>SUNG MOO JE</creatorcontrib><creatorcontrib>DAGOSTIN CLAUDIO</creatorcontrib><creatorcontrib>BROOKS CLINTON ALAN</creatorcontrib><creatorcontrib>HE GUO</creatorcontrib><creatorcontrib>HOWARD STEVEN</creatorcontrib><creatorcontrib>WRONA WOJCIECH</creatorcontrib><creatorcontrib>LAGU BHARAT</creatorcontrib><creatorcontrib>SMITH TROY D</creatorcontrib><creatorcontrib>WOODHEAD STEVEN JOHN</creatorcontrib><creatorcontrib>MORTENSON PAUL NEIL</creatorcontrib><creatorcontrib>BRAIN CHRISTOPHER THOMAS</creatorcontrib><creatorcontrib>CONGREVE MILES STUART</creatorcontrib><creatorcontrib>HOU YING</creatorcontrib><creatorcontrib>LU YIPIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BESONG GILBERT EBAI</au><au>LI YUE</au><au>SUNG MOO JE</au><au>DAGOSTIN CLAUDIO</au><au>BROOKS CLINTON ALAN</au><au>HE GUO</au><au>HOWARD STEVEN</au><au>WRONA WOJCIECH</au><au>LAGU BHARAT</au><au>SMITH TROY D</au><au>WOODHEAD STEVEN JOHN</au><au>MORTENSON PAUL NEIL</au><au>BRAIN CHRISTOPHER THOMAS</au><au>CONGREVE MILES STUART</au><au>HOU YING</au><au>LU YIPIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pyrrolopyrimidine compounds and their uses</title><date>2014-04-01</date><risdate>2014</risdate><abstract>The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US8685980B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Pyrrolopyrimidine compounds and their uses |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A07%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BESONG%20GILBERT%20EBAI&rft.date=2014-04-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8685980B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |